These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17926249)

  • 1. [Recent examples for drug (developments) in primary, secondary and tertiary prevention].
    Bramlage P; Schindler C; Schmidt AC; Bramlage CP; Kirch W
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2212-6. PubMed ID: 17926249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A patient with cardiovascular risk factors and comorbidities: integration of indications and contra-indications in pharmacotherapy].
    Scheen AJ
    Rev Med Liege; 2010; 65(7-8):476-81. PubMed ID: 20857708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of the obese patient in primary care: targeting and meeting goals and expectations.
    Bray G; Look M; Ryan D
    Postgrad Med; 2013 Sep; 125(5):67-77. PubMed ID: 24113665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular prevention: components, levels, early origins, and metrics.
    Kones R; Rumana U
    Hosp Pract (1995); 2014 Aug; 42(3):84-95. PubMed ID: 25255410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early intervention and prevention of myocardial infarction.
    Pais PS
    J Hypertens Suppl; 2006 Apr; 24(2):S25-30. PubMed ID: 16601557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of metabolic syndrome and associated cardiovascular risk factors.
    De Flines J; Scheen AJ
    Acta Gastroenterol Belg; 2010; 73(2):261-6. PubMed ID: 20690566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [When should we start the treatment of the cardiovascular risk factors].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2008; 125(1):125-36; discussion 136-44. PubMed ID: 18777847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidaemia: integration between primary and secondary care.
    Skinner JS
    Clin Med (Lond); 2011 Jun; 11(3):258-60. PubMed ID: 21902080
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian].
    Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC; González-Timón B; González-Juanatey JR
    Med Clin (Barc); 2013 Nov; 141(10):430-6. PubMed ID: 23246165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity.
    Taylor JR; Dietrich E; Powell JG
    Clin Ther; 2013 Jan; 35(1):A3-17. PubMed ID: 23328274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is type-2 diabetes mellitus preventable?].
    Jermendy G
    Orv Hetil; 2003 Sep; 144(39):1909-17. PubMed ID: 14598569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary prevention of type 2 diabetes mellitus according to lifestyle intervention--the process and for the future].
    Kosaka K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():52-99. PubMed ID: 12386979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reconsideration of Secondary Risk Management Strategies in Patients with Ischemic Heart Disease].
    Kashiyama K; Sonoda S; Otsuji Y
    J UOEH; 2017; 39(1):11-24. PubMed ID: 28331118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing?
    Teoh H; Després JP; Dufour R; Fitchett DH; Goldin L; Goodman SG; Harris SB; Langer A; Lau DC; Lonn EM; John Mancini GB; McFarlane PA; Poirier P; Rabasa-Lhoret R; Tan MK; Leiter LA
    Can J Cardiol; 2013 Aug; 29(8):960-8. PubMed ID: 23465284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonfatal acute myocardial infarction in Costa Rica: modifiable risk factors, population-attributable risks, and adherence to dietary guidelines.
    Kabagambe EK; Baylin A; Campos H
    Circulation; 2007 Mar; 115(9):1075-81. PubMed ID: 17339565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.